The White House

Office of the National Drug Control Policy

Statement from White House Drug Policy Director on the Food and Drug Administration’s Public Hearing Regarding the Role of Naloxone in Opioid Overdose Fatality Prevention

(Washington, D.C.)  -  Today, Gil Kerlikowske, Director of the Office of National Drug Control Policy, released the following statement:
 
“On behalf of the White House Office of National Drug Control Policy, I would like to thank everyone working on the important issue of overdose fatality prevention.  In 2010, the Obama Administration released its inaugural National Drug Control Strategy, which recognizes the important role naloxone can play in reversing drug overdoses.  With more people dying from unintentional drug overdoses than car accidents, it is vitally important that we do what is necessary to prevent drug abuse, while also preventing drug overdoses and getting people the treatment they need.  I look forward to continuing this important conversation and continuing to support evidenced-based ways to protect public health and safety and prevent overdoses.”